| The stock is undergoing a technical consolidation phase following the completion of the Biocare Medical acquisition, with price action currently hovering near critical moving average support.
Medium-Term (1-3 months) Summary:
The trend structure remains positive, with the 50-day MA trending upward.
Bullish: Synergies from the Biocare acquisition and consistent earnings beats.
Bearish: Potential for broader market volatility affecting healthcare multiples.
Signal rationale: Solid fundamental growth prospects and a supportive MA50 trend suggest continued medium-term strength.
Why watch?
1️⃣ Very high institutional ownership at over 90% provides significant price stability and long-term support.
2️⃣ Beat earnings estimates in all of the last 4 quarters
3️⃣ Excellent financial health (Piotroski 9/9)
| 
